WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[WuXi PharmaTech (Cayman) Inc. Form 6-K Press Release dated July 15, 2010 99.1 Presentation 99.2 WuXi PharmaTech (Cayman) Inc.]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[WuXi PharmaTech (Cayman) Inc. Form 6-K Press Release dated July 13, 2010 99.1 Charles River and WuXi Investor Presentation 99.2 WuXi Investor Presentation 99.3]
WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K Press Release
[WuXi PharmaTech (Cayman) Inc. Form 6-K Press Release dated July 13, 2010 99.1 Charles River and WuXi Investor Presentation 99.2 WuXi Investor Presentation 99.3]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[WuXi PharmaTech (Cayman) Inc. Form 6-K Disclosure Charles River WuXi Antitrust Division FTC HSR Act Transaction As previously disclosed, both Charles River Laboratories International, Inc. ( second request On July 12, 2010, WuXi received a Request for Additional Information (commonly referred to as a Completion of the Transaction remains subject to the approval of both Charles River and WuXi]
WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K Disclosure Charles
[WuXi PharmaTech (Cayman) Inc. Form 6-K Disclosure Charles River WuXi Antitrust Division FTC HSR Act Transaction As previously disclosed, both Charles River Laboratories International, Inc. ( second request On July 12, 2010, WuXi received a Request for Additional Information (commonly referred to as a Completion of the Transaction remains subject to the approval of both Charles River and WuXi]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[IMPORTANT REMINDER July 1, 2010 Dear Shareholder: We have previously mailed to you proxy materials relating to the Annual Meeting of Shareholders scheduled to be held on Thursday, July 15, 2010. According to our latest records, we have not received your proxy card for this important meeting. Regardless of the number of shares you own, it is important that they] [IMPORTANT ANNUAL MEEING IS SCHEDULED FOR JULY 15, 2010 PLEASE INSTRUCT YOUR BROKER TO VOTE TODAY! July 1, 2010 Dear Fellow Shareholder: Your vote is extremely important, regardless of the number of shares that you own. Please instruct your broker how to vote your shares today to avoid additional solicitation costs. According to our latest records, your broker has not] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
SVA [SINOVAC BIOTECH] 6-K: IMPORTANT REMINDER July 1, 2010 Dear Shareholder: We
[IMPORTANT REMINDER July 1, 2010 Dear Shareholder: We have previously mailed to you proxy materials relating to the Annual Meeting of Shareholders scheduled to be held on Thursday, July 15, 2010. According to our latest records, we have not received your proxy card for this important meeting. Regardless of the number of shares you own, it is important that they] [IMPORTANT ANNUAL MEEING IS SCHEDULED FOR JULY 15, 2010 PLEASE INSTRUCT YOUR BROKER TO VOTE TODAY! July 1, 2010 Dear Fellow Shareholder: Your vote is extremely important, regardless of the number of shares that you own. Please instruct your broker how to vote your shares today to avoid additional solicitation costs. According to our latest records, your broker has not] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[BIOSTAR PHARMACEUTICALS, INC. APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar. His expertise includes financial management, financing transactions, corporate governance and investor relations. Most recently, Mr. Chen was an independent advisor engaged in local RMB PE fundraising and providing M&A and]
BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. APPOINTS NEW CHIEF FINANCIAL OFFICER
[BIOSTAR PHARMACEUTICALS, INC. APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar. His expertise includes financial management, financing transactions, corporate governance and investor relations. Most recently, Mr. Chen was an independent advisor engaged in local RMB PE fundraising and providing M&A and]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[BIOSTAR PHARMACEUTICALS, APPOINTS NEW CHIEF FINANCIAL OFFICER XIANYANG, China, July 6, 2010 (Xinhua-PRNewswire-FirstCall) Mr. Chen brings more than 13 years of multinational and Big 4 accounting experiences to Biostar.His expertiseludes financial management, financing transactions,rporate governance and investor relations.Most recently, Mr. Chen was an independentvisor engaged in local RMB PE fundraising and providing M&A and PEvisory]
